Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
Heart failure (HF) represents the terminal stage of cardiovascular disease and remains a leading cause of mortality. Epidemiological studies indicate a high prevalence and mortality rate of HF globally. Current treatment options primarily include pharmacological and non-pharmacological approaches. W...
Saved in:
| Main Authors: | Chengqian Chen, Wentao Zhong, Hao Zheng, Wei Zhao, Yushi Wang, Botao Shen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1518036/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress in the study of the role of mesenchymal stem cell exosomes in heart transplant rejection
by: LIU Dezhao, et al.
Published: (2024-11-01) -
Exosomes derived from liver failure patients’ plasma stimulated mesenchymal stem cells alleviate acute liver failure
by: Zhuoran Wang, et al.
Published: (2025-02-01) -
Mesenchymal stem cells and exosomes: A novel therapeutic approach for aging
by: Dongfeng Lan, et al.
Published: (2025-07-01) -
Preventing the rejection of skin allografts by immunomodulatory and regenerative effects of exosomes derived from bone marrow mesenchymal stem cells in mice
by: Parham Soufizadeh, et al.
Published: (2025-04-01) -
The Potential of Mesenchymal Stem Cell-Derived Exosomes to Treat Diabetes Mellitus
by: Ju-El Kim, et al.
Published: (2025-01-01)